Long‐term maintenance therapy with azathioprine in systemic lupus erythematosus

Arthritis & Rheumatism

Volumn 18, Issue 1, 1975, Pages 27-34

  Ginzler, Ellen ^a,b   Sharon, Ezra ^a,b   Diamond, Herbert ^a,b   Kaplan, David ^a,b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b KINGS COUNTY HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; PREDNISONE;

ADVERSE DRUG REACTION; CENTRAL NERVOUS SYSTEM; COMA; DRUG COMPARISON; DRUG THERAPY; KIDNEY; KIDNEY FAILURE; LEUKOPENIA; LIVER TOXICITY; NEPHROTIC SYNDROME; ORAL DRUG ADMINISTRATION; ORGANIC BRAIN SYNDROME; RASH; SEIZURE; SYSTEMIC LUPUS ERYTHEMATOSUS; THERAPY; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; AZATHIOPRINE; BIOPSY; CENTRAL NERVOUS SYSTEM DISEASES; FEMALE; HOSPITALIZATION; HUMAN; KIDNEY DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGE; NEPHROTIC SYNDROME; PREDNISONE; PREGNANCY; PROGNOSIS; TIME FACTORS;

EID: 0016770049     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780180106     Document Type: Article

References (25)

1. Azathioprine and prednisone in the treatment of adults with lupus nephritis.
2. The effect of azathioprine on lupus glomerulonephritis.
3. Treatment of lupus nephritis with azathioprine.
4. Effect of azathioprine on renal histology and function in lupus nephritis.
5. Azathioprine in the treatment of systemic lupus erythematosus: a controlled study.
6. Preliminary criteria for the classification of systemic lupus erythematosus.
7. The clinical course of the proliferative and membranous forms of lupus nephritis.
8. Treatment of lupus nephritis with prednisone and combined prednisone and azathioprine.
9. Renal histologic findings in systemic lupus erythematosus.
10. Exacerbation of systemic lupus erythematosus after withdrawal of azathioprine therapy.
11. Microbiologic aspects of cytotoxic drug therapy.
12. Generalized cytomegalovirus infection in a patient with lupoid hepatitis.
13. Coccidioidal choroiditis following renal transplantation.
14. Malignant tumours following immunosuppressive therapy.
15. De‐novo brain tumours in renal transplant recipients.
16. Reticulum cell sarcoma after renal homotransplantation and azathioprine and prednisone therapy.
17. Development of malignant cerebral lymphoma in a patient with systemic lupus erythematosus treated with immunosuppression.
18. Chromosomes in patients treated with Imuran.
19. Chromosome studies in patients treated with azathioprine and amethopterin.
20. Birth defects in child of male recipient of kidney transplant.
21. Possible usefulness of azathioprine (Imuran) in severe rheumatoid arthritis.
22. Cytotoxic drugs in treatment of nonmalignant diseases.
23. Hepatic dysfunction after renal transplantation in children.
24. Acute pancreatitis as a complication of Imuran therapy in regional enteritis.
25. Intrahepatic cholestasis due to azathioprine.